Mereo BioPharma Group plc
MREO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001719714
No open-market purchases or sales by Mereo BioPharma Group plc insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $18.0M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Mereo BioPharma Group plc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 64 | 63 | −1 |
| Shares | 67.1M | 68.0M | +865.5K (+1.3%) |
| Value | $82.7M | $58.5M | −$24.1M (−29.2%) |
New holders (9)
Institutions that held Mereo BioPharma Group plc at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Monaco Asset Management SAM | 186,656 | $161.0K | 0.07% |
| Privium Fund Management (UK) Ltd | 177,200 | $153.0K | 0.20% |
| Envestnet Asset Management Inc | 37,367 | $32.0K | 0.00% |
| Virtu Financial LLC | 33,880 | $29.0K | 0.00% |
| Creative Planning | 25,820 | $22.0K | 0.00% |
| Balyasny Asset Management LLC | 19,211 | $17.0K | 0.00% |
| TCWP LLC | 10,000 | $8.00K | 0.00% |
| China Universal Asset Management Co., Ltd. | 1,095 | $1.00K | 0.00% |
| Axiom Investment Management LLC | 1 | $0 | 0.00% |
Sold out (10)
Institutions that held Mereo BioPharma Group plc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Ergoteles LLC | 529,300 | $593.0K |
| Sectoral Asset Management Inc | 385,000 | $431.0K |
| Ikarian Capital, LLC | 615,856 | $199.0K |
| Silverarc Capital Management, LLC | 156,195 | $175.0K |
| Boothbay Fund Management, LLC | 55,532 | $62.0K |
| HRT Financial LP | 39,886 | $44.0K |
| Hall Capital Management Co Inc | 10,000 | $11.0K |
| Parallax Volatility Advisers, L.P. | 10,000 | $11.0K |
| Spire Wealth Management | 2,500 | $3.00K |
| Total Clarity Wealth Management, Inc. | 2,000 | $2.00K |